- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 76.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 76.31M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 72.92M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.5M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$600K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$47.2M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $19.5M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $14.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $374.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $385M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $518M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $533.6M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $545.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $593.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.44B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.39B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.96B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.93B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.86 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.47 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.86 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $42.2M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $35.9M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $26.9M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $22M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$35.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$62.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $258M |
| Revenue | Q1 2026 · Mar 31, 2025 | $151.2M |